Founded in 2011, Claritas Rx emerged from a critical gap in the specialty pharmaceutical industry: manufacturers lacked visibility into what happened to patients after prescriptions left their offices. In complex specialty networks where medications could travel through specialty distributors, pharmacies, and hub services, biopharma companies were essentially flying blind - unable to see the real-world barriers that prevented patients from starting or staying on life-changing treatments. Our founders realized that without this visibility, manufacturers couldn't optimize patient access, improve adherence, or truly understand therapy performance in the real world.
Today, Claritas Rx has grown from a small channel data consultancy into a pioneering healthcare technology company that illuminates the complete patient journey. Our intelligent Claritas Rx Ascend platform unifies fragmented healthcare data from specialty pharmacies, distributors, and hubs, then applies AI and predictive modeling to identify barriers before they disrupt care. With 95% patient match accuracy and the ability to increase fill rates by 20% in complex cases, we've transformed from data aggregators to trusted partners who help rare disease and specialty brands remove access barriers - ensuring patients not only start therapy but stay on it. From our headquarters in South San Francisco, our team of patient journey experts continues pushing the boundaries of what's possible in specialty analytics, because we believe progress means every patient journey counts.
